Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

The Tumor Microenvironment02:17

The Tumor Microenvironment

8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

SmartAlert - Implementing Machine Learning-Driven Clinical Decision Support for Inpatient Laboratory Utilization Reduction.

NEJM AI·2026
Same author

Why and How to Monitor Deployed AI Systems in Health Care.

NEJM catalyst innovations in care delivery·2026
Same author

BRIDGE: benchmarking large language models for understanding real-world clinical practice texts.

Nature biomedical engineering·2026
Same author

Micro-randomization trial design under operational constraints.

Contemporary clinical trials·2026
Same author

What the AI era doctor should know: a scoping review of proposed artificial intelligence competencies for medical education.

NPJ digital medicine·2026
Same author

Physician-Reported Safety Outcomes of AI-Generated Hospital Course Summaries.

JAMA network open·2026

Video Experimental Relacionado

Updated: Mar 3, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K

El metal pesado aclara la inmunidad tumoral

Jonathan H Chen1, Karin Pelka2, Nir Hacohen2

  • 1Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.

Cell
|May 6, 2017
PubMed
Resumen

Comprender el panorama inmune en los cánceres humanos es crucial para una inmunoterapia efectiva. Dos estudios recientes utilizaron citometría de masa para analizar las células inmunes en el adenocarcinoma pulmonar y el carcinoma renal de células claras.

Más Videos Relacionados

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

868
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Videos de Experimentos Relacionados

Last Updated: Mar 3, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

8.2K
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
08:25

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

868
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.8K

Área de la Ciencia:

  • Inmunología
  • En el campo de la oncología
  • Biotecnología

Sus antecedentes:

  • El desarrollo de inmunoterapias eficaces contra el cáncer requiere una comprensión detallada del microambiente inmune del tumor.
  • Investigaciones anteriores han destacado la heterogeneidad de los infiltrados inmunes en diferentes tipos de cáncer.

Objetivo del estudio:

  • Para investigar la composición de las células inmunes en el adenocarcinoma pulmonar y el carcinoma renal de células claras.
  • Proporcionar información sobre el paisaje inmune que podría informar futuras estrategias de inmunoterapia.

Principales métodos:

  • Se empleó citometría de masa (citometría por tiempo de vuelo) para realizar análisis de células únicas de alta dimensión.
  • Las infiltraciones inmunes dentro de los tejidos tumorales fueron caracterizadas meticulosamente.

Principales resultados:

  • Perfiles detallados de las poblaciones de células inmunes y su distribución espacial en el adenocarcinoma pulmonar.
  • Análisis exhaustivo de los infiltrados inmunes en el carcinoma renal de células claras, revelando firmas inmunes distintas.

Conclusiones:

  • La citometría de masa ofrece un enfoque poderoso para diseccionar infiltrados inmunes complejos en cánceres humanos.
  • Estos hallazgos contribuyen a una comprensión más profunda de la inmunidad contra el cáncer, allanando el camino para mejorar las intervenciones inmunoterapéuticas.